Redeye revises its estimates after reviewing Norse Impact’s Q4 2022 report. While the quarter’s financials were almost in line with expectations, the gross margin increase and better sales of in-house brands indicate a positive outlook for the future. As a result, Redeye raises its valuation.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/
© Modular Finance, source